{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:22:20Z","timestamp":1785252140344,"version":"3.55.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ontario Graduate Scholarship"},{"DOI":"10.13039\/501100002790","name":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,4,7]]},"DOI":"10.1038\/s41388-026-03702-2","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:27:54Z","timestamp":1772699274000},"page":"1111-1127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Jack D.","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Buensuceso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4528-3713","authenticated-orcid":false,"given":"Emily J.","family":"Tomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Viola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Hovey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudith","family":"Ramos Valdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipradeb","family":"Singha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-9035","authenticated-orcid":false,"given":"Shawn S-C","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1853-8066","authenticated-orcid":false,"given":"Trevor G.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"3702_CR1","doi-asserted-by":"publisher","first-page":"E199","DOI":"10.1503\/cmaj.191292","volume":"192","author":"DR Brenner","year":"2020","unstructured":"Brenner DR, Weir HK, Demers AA, Ellison LF, Louzado C, Shaw A, et al. Projected estimates of cancer in Canada in 2020. Can Med Assoc J. 2020;192:E199\u2013E205. https:\/\/doi.org\/10.1503\/cmaj.191292.","journal-title":"Can Med Assoc J"},{"key":"3702_CR2","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393:1240\u201353. https:\/\/doi.org\/10.1016\/S0140-6736(18)32552-2.","journal-title":"Lancet"},{"key":"3702_CR3","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2013.321","volume":"33","author":"E Lengyel","year":"2014","unstructured":"Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, et al. Epithelial ovarian cancer experimental models. Oncogene. 2014;33:3619\u201333. https:\/\/doi.org\/10.1038\/onc.2013.321.","journal-title":"Oncogene"},{"key":"3702_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell DD, B\u00f6hm S, Ahmed AA, Aspuria PJ, Bast RC, Beral V, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15:668\u201379. https:\/\/doi.org\/10.1038\/nrc4019.","journal-title":"Nat Rev Cancer"},{"key":"3702_CR5","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.3390\/ijms23116215","volume":"23","author":"M Rakina","year":"2022","unstructured":"Rakina M, Kazakova A, Villert A, Kolomiets L, Larionova I. Spheroid formation and peritoneal metastasis in ovarian cancer: the role of stromal and immune components. Int J Mol Sci. 2022;23:6215. https:\/\/doi.org\/10.3390\/ijms23116215.","journal-title":"Int J Mol Sci"},{"key":"3702_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01145-x","volume":"16","author":"E Tomas","year":"2023","unstructured":"Tomas E, Shepherd TG. Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems. J Ovarian Res. 2023;16:70. https:\/\/doi.org\/10.1186\/s13048-023-01145-x.","journal-title":"J Ovarian Res"},{"key":"3702_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","volume":"1","author":"MP Iwanicki","year":"2011","unstructured":"Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, et al. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. 2011;1:144\u201357. https:\/\/doi.org\/10.1158\/2159-8274.CD-11-0010.","journal-title":"Cancer Discov"},{"key":"3702_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/carcin\/bgr241","volume":"33","author":"RJM Correa","year":"2012","unstructured":"Correa RJM, Peart T, Valdes YR, Dimattia GE, Shepherd TG. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis. 2012;33:49\u201358. https:\/\/doi.org\/10.1093\/carcin\/bgr241.","journal-title":"Carcinogenesis"},{"key":"3702_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1530\/ERC-15-0383","volume":"23","author":"S Rafehi","year":"2016","unstructured":"Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Pr\u00e9fontaine M, Sugimoto A, et al. TGF\u03b2 signaling regulates Epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Endocr Relat Cancer. 2016;23:147\u201359. https:\/\/doi.org\/10.1530\/ERC-15-0383.","journal-title":"Endocr Relat Cancer"},{"key":"3702_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1158\/1541-7786.MCR-19-0530","volume":"18","author":"A Buensuceso","year":"2020","unstructured":"Buensuceso A, Ramos-Valdes Y, DiMattia GE, Shepherd TG. AMPK-independent LKB1 activity is required for efficient epithelial ovarian cancer metastasis. Mol Cancer Res. 2020;18:488\u2013500. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0530.","journal-title":"Mol Cancer Res"},{"key":"3702_CR11","doi-asserted-by":"publisher","first-page":"22424","DOI":"10.18632\/oncotarget.4211","volume":"6","author":"T Peart","year":"2015","unstructured":"Peart T, Valdes YR, Correa RJM, Fazio E, Bertrand M, McGee J, et al. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids. Oncotarget. 2015;6:22424\u201338. https:\/\/doi.org\/10.18632\/oncotarget.4211.","journal-title":"Oncotarget"},{"key":"3702_CR12","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/carcin\/bgu049","volume":"35","author":"RJM Correa","year":"2014","unstructured":"Correa RJM, Valdes YR, Peart TM, Fazio EN, Bertrand M, McGee J, et al. Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability. Carcinogenesis. 2014;35:1951\u201361. https:\/\/doi.org\/10.1093\/carcin\/bgu049.","journal-title":"Carcinogenesis"},{"key":"3702_CR13","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","volume":"1","author":"Y Aman","year":"2021","unstructured":"Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK, Bjedov I, et al. Autophagy in healthy aging and disease. Nat Aging. 2021;1:634\u201350. https:\/\/doi.org\/10.1038\/s43587-021-00098-4.","journal-title":"Nat Aging"},{"key":"3702_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/cells7120278","volume":"7","author":"Y Chun","year":"2018","unstructured":"Chun Y, Kim J. Autophagy: An essential degradation program for cellular homeostasis and life. Cells. 2018;7:278 https:\/\/doi.org\/10.3390\/cells7120278.","journal-title":"Cells"},{"key":"3702_CR15","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/ijms19113466","volume":"19","author":"CW Yun","year":"2018","unstructured":"Yun CW, Lee SH. The roles of autophagy in cancer. Int J Mol Sci. 2018;19:3466 https:\/\/doi.org\/10.3390\/ijms19113466.","journal-title":"Int J Mol Sci"},{"key":"3702_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ceb.2016.02.010","volume":"39","author":"MG Lin","year":"2016","unstructured":"Lin MG, Hurley JH. Functions of ULK1 in autophagy and non-autophagy pathways and its implications in human physiology and disease. Biocell. 2016;39:61\u20138. https:\/\/doi.org\/10.1016\/j.ceb.2016.02.010.","journal-title":"Biocell"},{"key":"3702_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38401-z","volume":"14","author":"JM Park","year":"2023","unstructured":"Park JM, Lee DH, Kim DH. Redefining the role of AMPK in autophagy and the energy stress response. Nat Commun. 2023;14:2994. https:\/\/doi.org\/10.1038\/s41467-023-38401-z.","journal-title":"Nat Commun"},{"key":"3702_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1042\/EBC20170021","volume":"61","author":"M Zachari","year":"2017","unstructured":"Zachari M, Ganley IG. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017;61:585\u201396. https:\/\/doi.org\/10.1042\/EBC20170021.","journal-title":"Essays Biochem"},{"key":"3702_CR19","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1158\/1535-7163.MCT-18-0176","volume":"17","author":"CM Dower","year":"2018","unstructured":"Dower CM, Bhat N, Gebru MT, Chen L, Wills CA, Miller BA, et al. Targeted inhibition of ULK1 promotes apoptosis and suppresses tumor growth and metastasis in neuroblastoma. Mol Cancer Ther. 2018;17:2365\u201376. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0176.","journal-title":"Mol Cancer Ther"},{"key":"3702_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13046-020-01580-4","volume":"39","author":"DY Hwang","year":"2020","unstructured":"Hwang DY, Eom JI, Jang JE, Jeung HK, Chung H, Kim JS, et al. ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia. J Exp Clin Cancer Res. 2020;39:85 https:\/\/doi.org\/10.1186\/s13046-020-01580-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"3702_CR21","doi-asserted-by":"publisher","unstructured":"Ghazi PC, O\u2019Toole KT, Srinivas Boggaram S, Scherzer MT, Silvis MR, Zhang Y, et al. Inhibition of ULK1\/2 and KRASG12C controls tumor growth in preclinical models of lung cancer. Elife. 2024; https:\/\/doi.org\/10.7554\/eLife.96992.","DOI":"10.7554\/eLife.96992"},{"key":"3702_CR22","doi-asserted-by":"publisher","unstructured":"Brun SN, Sancar G, Lumibao J, Limpert AS, Ren H, Ianniciello A, et al. The autophagy initiating kinase ULK1 is required for pancreatic cancer cell growth and survival. 2021; https:\/\/doi.org\/10.1101\/2021.05.15.444304.","DOI":"10.1101\/2021.05.15.444304"},{"key":"3702_CR23","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1080\/15548627.2019.1709762","volume":"16","author":"ST Xue","year":"2020","unstructured":"Xue ST, Li K, Gao Y, Zhao LY, Gao Y, Yi H, et al. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target. Autophagy. 2020;16:1823\u201337. https:\/\/doi.org\/10.1080\/15548627.2019.1709762.","journal-title":"Autophagy"},{"key":"3702_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-00660-5","volume":"13","author":"J Laski","year":"2020","unstructured":"Laski J, Singha B, Wang X, Vald\u00e9s YR, Collins O, Shepherd TG. Activated CAMKK\u03b2-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis. J Ovarian Res. 2020;13:58. https:\/\/doi.org\/10.1186\/s13048-020-00660-5.","journal-title":"J Ovarian Res"},{"key":"3702_CR25","first-page":"1384","volume":"10","author":"B Singha","year":"2020","unstructured":"Singha B, Laski J, Ramos Vald\u00e9s Y, Liu E, DiMattia GE, Shepherd TG. Inhibiting ULK1 kinase decreases autophagy and cell viability in high-grade serous ovarian cancer spheroids. Am J Cancer Res. 2020;10:1384\u201399.","journal-title":"Am J Cancer Res"},{"key":"3702_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell. 2013;24:751\u201365. https:\/\/doi.org\/10.1016\/j.ccr.2013.10.013.","journal-title":"Cancer Cell"},{"key":"3702_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/embor.2008.238","volume":"10","author":"EN N'Diaye","year":"2009","unstructured":"N'Diaye EN, Kajihara KK, Hsieh I, Morisaki H, Debnath J, Brown EJ. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 2009;10:173\u20139. https:\/\/doi.org\/10.1038\/embor.2008.238.","journal-title":"EMBO Rep"},{"key":"3702_CR28","doi-asserted-by":"publisher","first-page":"e0232565","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo A, Torres Figueroa F, Clavijo C, Arbel\u00e1ez P, Cruz JC, Mu\u00f1oz-Camargo C. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS One. 2020;15:e0232565 https:\/\/doi.org\/10.1371\/journal.pone.0232565.","journal-title":"PLoS One"},{"key":"3702_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382. https:\/\/doi.org\/10.1038\/nmeth.2019.","journal-title":"Nat Methods"},{"key":"3702_CR30","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1093\/bioinformatics\/btx180","volume":"33","author":"I Arganda-Carreras","year":"2017","unstructured":"Arganda-Carreras I, Kaynig V, Rueden C, Eliceiri KW, Schindelin J, Cardona A, et al. Trainable Weka Segmentation: A machine learning tool for microscopy pixel classification. Bioinformatics. 2017;33:2424\u20136. https:\/\/doi.org\/10.1093\/bioinformatics\/btx180.","journal-title":"Bioinformatics"},{"key":"3702_CR31","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A. IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 2014;9:e96801 https:\/\/doi.org\/10.1371\/journal.pone.0096801.","journal-title":"PLoS One"},{"key":"3702_CR32","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36:2628\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz931.","journal-title":"Bioinformatics"},{"key":"3702_CR33","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 2024;52:D672\u2013D678. https:\/\/doi.org\/10.1093\/nar\/gkad1025.","journal-title":"Nucleic Acids Res"},{"key":"3702_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","volume":"21","author":"WJ Liu","year":"2016","unstructured":"Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett. 2016;21:29 https:\/\/doi.org\/10.1186\/s11658-016-0031-z.","journal-title":"Cell Mol Biol Lett"},{"key":"3702_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46657-z","volume":"9","author":"G Runwal","year":"2019","unstructured":"Runwal G, Stamatakou E, Siddiqi FH, Puri C, Zhu Y, Rubinsztein DC. LC3-positive structures are prominent in autophagy-deficient cells. Sci Rep. 2019;9:10147. https:\/\/doi.org\/10.1038\/s41598-019-46657-z.","journal-title":"Sci Rep"},{"key":"3702_CR36","doi-asserted-by":"publisher","unstructured":"Gammoh N. The multifaceted functions of ATG16L1 in autophagy and related processes. J Cell Sci. 2020;133. https:\/\/doi.org\/10.1242\/jcs.249227.","DOI":"10.1242\/jcs.249227"},{"key":"3702_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/15548627.2017.1422851","volume":"14","author":"JM Park","year":"2018","unstructured":"Park JM, Seo M, Jung CH, Grunwald D, Stone M, Otto NM, et al. ULK1 phosphorylates Ser30 of BECN1 in association with ATG14 to stimulate autophagy induction. Autophagy. 2018;14:584\u201397. https:\/\/doi.org\/10.1080\/15548627.2017.1422851.","journal-title":"Autophagy"},{"key":"3702_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/GCO.0000000000000340","volume":"29","author":"PT Kroeger","year":"2017","unstructured":"Kroeger PT, Drapkin R. Pathogenesis and heterogeneity of ovarian cancer. Curr Opin Obstet Gynecol. 2017;29:26\u201334. https:\/\/doi.org\/10.1097\/GCO.0000000000000340.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"3702_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67780-2","volume":"10","author":"A Demeter","year":"2020","unstructured":"Demeter A, Romero-Mulero MC, Csabai L, \u00d6lbei M, Sudhakar P, Haerty W, et al. ULK1 and ULK2 are less redundant than previously thought: computational analysis uncovers distinct regulation and functions of these autophagy induction proteins. Sci Rep. 2020;10:10940. https:\/\/doi.org\/10.1038\/s41598-020-67780-2.","journal-title":"Sci Rep"},{"key":"3702_CR40","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","volume":"37","author":"S Al Habyan","year":"2018","unstructured":"Al Habyan S, Kalos C, Szymborski J, McCaffrey L. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Oncogene. 2018;37:5127\u201335. https:\/\/doi.org\/10.1038\/s41388-018-0317-x.","journal-title":"Oncogene"},{"key":"3702_CR41","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-07-6849","volume":"68","author":"D Barkan","year":"2008","unstructured":"Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 2008;68:6241\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6849.","journal-title":"Cancer Res"},{"key":"3702_CR42","doi-asserted-by":"publisher","unstructured":"Davidowitz RA, Iwanicki MP, Brugge JS. In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis. J Vis Exp. 2012; https:\/\/doi.org\/10.3791\/3888.","DOI":"10.3791\/3888"},{"key":"3702_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","volume":"13","author":"H Chang","year":"2020","unstructured":"Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol. 2020;13:159 https:\/\/doi.org\/10.1186\/s13045-020-01000-2.","journal-title":"J Hematol Oncol"},{"key":"3702_CR44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ygyno.2021.12.025","volume":"164","author":"A Poveda","year":"2022","unstructured":"Poveda A, Lheureux S, Colombo N, Cibula D, Lindemann K, Weberpals J, et al. Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1\/BRCA2 mutation: OPINION primary analysis. Gynecol Oncol. 2022;164:498\u2013504. https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.025.","journal-title":"Gynecol Oncol"},{"key":"3702_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-022-00079-y","volume":"17","author":"TG Shepherd","year":"2022","unstructured":"Shepherd TG, Dick FA. Principles of dormancy evident in high-grade serous ovarian cancer. Cell Div. 2022;17:2. https:\/\/doi.org\/10.1186\/s13008-022-00079-y.","journal-title":"Cell Div"},{"key":"3702_CR46","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK\/MAPK signalling pathway and tumorigenesis (Review). Exp Ther Med. 2020;19:1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454.","journal-title":"Exp Ther Med"},{"key":"3702_CR47","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.3390\/ijms22094929","volume":"22","author":"E Vargas-Accarino","year":"2021","unstructured":"Vargas-Accarino E, Herrera-Mont\u00e1vez C, Ram\u00f3n y Cajal S, Aasen T. Spontaneous cell detachment and reattachment in cancer cell lines: an in vitro model of metastasis and malignancy. Int J Mol Sci. 2021;22:4929 https:\/\/doi.org\/10.3390\/ijms22094929.","journal-title":"Int J Mol Sci"},{"key":"3702_CR48","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","volume":"45","author":"B Gy\u0151rffy","year":"2023","unstructured":"Gy\u0151rffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023;45:1889\u201398. https:\/\/doi.org\/10.1007\/s11357-023-00742-4.","journal-title":"Geroscience"},{"key":"3702_CR49","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/ijms22052622","volume":"22","author":"\u00c1 Bartha","year":"2021","unstructured":"Bartha \u00c1, Gy\u0151rffy B. Tnmplot.Com: A web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22:2622 https:\/\/doi.org\/10.3390\/ijms22052622.","journal-title":"Int J Mol Sci"},{"key":"3702_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0182-y","volume":"8","author":"RJM Correa","year":"2015","unstructured":"Correa RJM, Valdes YR, Shepherd TG, DiMattia GE. Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro. J Ovarian Res. 2015;8:52. https:\/\/doi.org\/10.1186\/s13048-015-0182-y.","journal-title":"J Ovarian Res"},{"key":"3702_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.isci.2019.07.049","volume":"19","author":"LJ Wheeler","year":"2019","unstructured":"Wheeler LJ, Watson ZL, Qamar L, Yamamoto TM, Sawyer BT, Sullivan KD, et al. Multi-omic approaches identify metabolic and autophagy regulators important in ovarian cancer dissemination. iScience. 2019;19:474\u201391. https:\/\/doi.org\/10.1016\/j.isci.2019.07.049.","journal-title":"iScience"},{"key":"3702_CR52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4161\/auto.7.7.15450","volume":"7","author":"EJ Lee","year":"2011","unstructured":"Lee EJ, Tournier C. The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy. Autophagy. 2011;7:689\u201395. https:\/\/doi.org\/10.4161\/auto.7.7.15450.","journal-title":"Autophagy"},{"key":"3702_CR53","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta Mol Cell Res. 2013;1833:3481\u201398. https:\/\/doi.org\/10.1016\/j.bbamcr.2013.06.026.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3702_CR54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/1541-7786.MCR-16-0200-T","volume":"15","author":"JL Chen","year":"2017","unstructured":"Chen JL, David J, Cook-Spaeth D, Casey S, Cohen D, Selvendiran K, et al. Autophagy induction results in enhanced anoikis resistance in models of peritoneal disease. Mol Cancer Res. 2017;15:26\u201334. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0200-T.","journal-title":"Mol Cancer Res"},{"key":"3702_CR55","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3892\/mmr.2014.1952","volume":"9","author":"L Cao","year":"2014","unstructured":"Cao L, Zhang Z, Han L, Du J, Liang X, Liu Y, et al. Mitogen-activated protein kinase pathway is pivotal for anoikis resistance in metastatic hepatoma cells. Mol Med Rep. 2014;9:1121\u20137. https:\/\/doi.org\/10.3892\/mmr.2014.1952.","journal-title":"Mol Med Rep"},{"key":"3702_CR56","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.1099993","volume":"306","author":"T Shintani","year":"2004","unstructured":"Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science. 2004;306:990\u20135. https:\/\/doi.org\/10.1126\/science.1099993.","journal-title":"Science"},{"key":"3702_CR57","doi-asserted-by":"publisher","unstructured":"Zhou Z, Zhao J, Liu Y, Yan X, Sun H, Xia M, et al. Autophagy promotes invadopodia formation in human ovarian cancer cells via the p952-extracellular signal-regulated kinase 1\/2 pathway. Exp Ther Med. 2021;22. https:\/\/doi.org\/10.3892\/etm.2021.10384.","DOI":"10.3892\/etm.2021.10384"},{"key":"3702_CR58","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1080\/15548627.2020.1850609","volume":"17","author":"R Deng","year":"2021","unstructured":"Deng R, Zhang HL, Huang JH, Cai RZ, Wang Y, Chen YH, et al. MAPK1\/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis. Autophagy. 2021;17:3011\u201329. https:\/\/doi.org\/10.1080\/15548627.2020.1850609.","journal-title":"Autophagy"},{"key":"3702_CR59","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/cancers11081044","volume":"11","author":"N Thomakos","year":"2019","unstructured":"Thomakos N, Diakosavvas M, Machairiotis N, Fasoulakis Z, Zarogoulidis P, Rodolakis A. Rare distant metastatic disease of ovarian and peritoneal carcinomatosis: a review of the literature. Cancers. 2019;11:1044 https:\/\/doi.org\/10.3390\/cancers11081044.","journal-title":"Cancers"},{"key":"3702_CR60","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1158\/1055-9965.EPI-20-1817","volume":"30","author":"MCJ Quinn","year":"2021","unstructured":"Quinn MCJ, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, et al. Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer. Cancer Epidemiol Biomark Prev. 2021;30:1669\u201380. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1817.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3702_CR61","doi-asserted-by":"publisher","unstructured":"Johnston TPA, Borrelli MJ, Tomas EJ, Vald\u00e9s YR, Pucchio AC, Shepherd TG. Investigating potential therapeutic synergism of MRT68921 and afatinib in three-dimensional models of epithelial ovarian cancer. 2025; https:\/\/doi.org\/10.3390\/cancers18020307.","DOI":"10.3390\/cancers18020307"},{"key":"3702_CR62","doi-asserted-by":"crossref","unstructured":"Xu JL, Yuan L, Tang YC, Xu ZY, Xu HD, Cheng XD, et al. The role of autophagy in gastric cancer chemoresistance: friend or foe? Front Cell Dev Biol. 2020;8:621428.","DOI":"10.3389\/fcell.2020.621428"},{"key":"3702_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10555-025-10250-w","volume":"44","author":"X Yang","year":"2025","unstructured":"Yang X, Cao X, Zhu Q. p62\/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair. Cancer Metastasis Rev. 2025;44:33 https:\/\/doi.org\/10.1007\/s10555-025-10250-w.","journal-title":"Cancer Metastasis Rev"},{"key":"3702_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/ijo.2021.5257","volume":"59","author":"J TANG","year":"2021","unstructured":"TANG J, LI Y, XIA S, LI J, YANG Q, DING K, et al. Sequestosome 1\/p62: a multitasker in the regulation of malignant tumor aggression (Review). Int J Oncol. 2021;59:77 https:\/\/doi.org\/10.3892\/ijo.2021.5257.","journal-title":"Int J Oncol"},{"key":"3702_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0954-x","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer. 2019;18:26. https:\/\/doi.org\/10.1186\/s12943-019-0954-x.","journal-title":"Mol Cancer"},{"key":"3702_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10248-5","volume":"22","author":"X Nie","year":"2022","unstructured":"Nie X, Liu D, Zheng M, Li X, Liu O, Guo Q, et al. HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K\/AKT\/mTOR and p38 MAPK signaling pathways. BMC Cancer. 2022;22:1338. https:\/\/doi.org\/10.1186\/s12885-022-10248-5.","journal-title":"BMC Cancer"},{"key":"3702_CR67","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3892\/or.2015.4212","volume":"34","author":"L Hu","year":"2015","unstructured":"Hu L, Cong L. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer. Oncol Rep. 2015;34:2683\u201391. https:\/\/doi.org\/10.3892\/or.2015.4212.","journal-title":"Oncol Rep"},{"key":"3702_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1083\/jcb.201701049","volume":"217","author":"Y He","year":"2018","unstructured":"He Y, She H, Zhang T, Xu H, Cheng L, Yepes M, et al. p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1. J Cell Biol. 2018;217:315\u201328. https:\/\/doi.org\/10.1083\/jcb.201701049.","journal-title":"J Cell Biol"},{"key":"3702_CR69","doi-asserted-by":"publisher","unstructured":"Fraser J, Simpson J, Fontana R, Kishi-Itakura C, Ktistakis NT, Gammoh N. Targeting of early endosomes by autophagy facilitates EGFR recycling and signalling. EMBO Rep. 2019;20; https:\/\/doi.org\/10.15252\/embr.201947734.","DOI":"10.15252\/embr.201947734"},{"key":"3702_CR70","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ygyno.2021.07.008","volume":"163","author":"P van der Ploeg","year":"2021","unstructured":"van der Ploeg P, Uittenboogaard A, Thijs AMJ, Westgeest HM, Boere IA, Lambrechts S, et al. The effectiveness of monotherapy with PI3K\/AKT\/mTOR pathway inhibitors in ovarian cancer: a meta-analysis. Gynecol Oncol. 2021;163:433\u201344. https:\/\/doi.org\/10.1016\/j.ygyno.2021.07.008.","journal-title":"Gynecol Oncol"},{"key":"3702_CR71","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/bjc.2012.368","volume":"107","author":"A Naing","year":"2012","unstructured":"Naing A, Aghajanian C, Raymond E, Olmos D, Schwartz G, Oelmann E, et al. Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma. Br J Cancer. 2012;107:1093\u20139. https:\/\/doi.org\/10.1038\/bjc.2012.368.","journal-title":"Br J Cancer"},{"key":"3702_CR72","doi-asserted-by":"publisher","first-page":"041","DOI":"10.1093\/noajnl\/vdad041","volume":"5","author":"JT Jordan","year":"2023","unstructured":"Jordan JT, Orr CC, Thalheimer RD, Cambillo JV, Beauchamp RL, Shaikh G, et al. Prospective phase II trial of the dual mTORC1\/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neurooncol Adv. 2023;5:041 https:\/\/doi.org\/10.1093\/noajnl\/vdad041.","journal-title":"Neurooncol Adv"},{"key":"3702_CR73","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jamaoncol.2022.1047","volume":"8","author":"P Heudel","year":"2022","unstructured":"Heudel P, Frenel JS, Dalban C, Bazan F, Joly F, Arnaud A, et al. Safety and efficacy of the mTOR inhibitor, vistusertib, combined with anastrozole in patients with hormone receptor\u2212positive recurrent or metastatic endometrial cancer. JAMA Oncol. 2022;8:1001 https:\/\/doi.org\/10.1001\/jamaoncol.2022.1047.","journal-title":"JAMA Oncol"},{"key":"3702_CR74","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(21)02175-9","volume":"399","author":"DM Gershenson","year":"2022","unstructured":"Gershenson DM, Miller A, Brady WE, Paul J, Carty K, Rodgers W, et al. Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281\/LOGS): an international, randomised, open-label, multicentre, phase 2\/3 trial. Lancet. 2022;399:541\u201353. https:\/\/doi.org\/10.1016\/S0140-6736(21)02175-9.","journal-title":"Lancet"},{"key":"3702_CR75","doi-asserted-by":"publisher","first-page":"100547","DOI":"10.1016\/j.gore.2020.100547","volume":"32","author":"S Cappuccio","year":"2020","unstructured":"Cappuccio S, Distefano MG, Ghizzoni V, Fagotti A, Scambia G. Trametinib response in heavily pretreated high-grade ovarian cancer: one step towards precision medicine. Gynecol Oncol Rep. 2020;32:100547 https:\/\/doi.org\/10.1016\/j.gore.2020.100547.","journal-title":"Gynecol Oncol Rep"},{"key":"3702_CR76","doi-asserted-by":"publisher","unstructured":"Chandana SR, Shepard DR, Mehnert JM, Chi P, Trent JC, Psoinos CM, et al. DCC-3116 in combination with ripretinib for patients with advanced gastrointestinal stromal tumor: a phase 1\/2 study. J Clin Oncol. 2025;42:TPS11587. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.TPS1158.","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS1158"},{"key":"3702_CR77","doi-asserted-by":"publisher","first-page":"19714","DOI":"10.1002\/cam4.6521","volume":"12","author":"WS Chan","year":"2023","unstructured":"Chan WS, Mo X, Ip PPC, Tse KY. Patient-derived organoid culture in epithelial ovarian cancers\u2014Techniques, applications, and future perspectives. Cancer Med. 2023;12:19714\u201331. https:\/\/doi.org\/10.1002\/cam4.6521.","journal-title":"Cancer Med"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03702-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03702-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03702-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:01:25Z","timestamp":1773702085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03702-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":77,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,4,7]]}},"alternative-id":["3702"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03702-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6148090\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Western Ontario (London, Ontario, Canada) and were performed in accordance with approved guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}